Displaying 126–150 of 309 results for USP
Celsis has expanded the analytical chemistry capabilities of its cGMP labs to include Mass Spectrometry (LC-MS/MS) and Ion Chromatography.
Within the past five years, more of world's regulatory agencies and pharmacopeias have gotten on the same wavelength.
Re-evaluated Material, New Approach and Calculation Tool to Help Pharmaceutical Manufacturers Comply with Quality Standards
Advantapure: BioClosures Systems Offer Secure Container Seals
From disposables to diaphragms, a look at whats new in valves for biopharma.
The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium ...
The new guidelines are evidence of multinational law enforcement at its best.
USP has released an updated version of its matrix tracking public reports of counterfeit and substandard drugs worldwide. The report is more anecdotal than comprehensivetheres no way to chronicle all incidentsbut tells a vivid story of the challenges facing local authorities worldwide in ...
Small but necessary steps towards new and improved standards
At the USP Science Meeting in Toronto last week, the topic of anticounterfeiting and assuring drug quality took center stage. A number of presentations addressed the use of analytical technologies to protect public health. Raman spectroscopy appears to be gaining use to help detect fakes in the ...
If youre heading towards the adoption of rapid microbial methods, youve got to be able to make a business case.
The United States Pharmacopeia (USP) has significantly changed the USP XXXI <61> Microbial Limits Test, updating it and dividing it into two parts
Ash Stevens shares information gained from years in the business, and how it will make a new CMC alliance work with various partners.
Significant changes include more clarity on enumberation and specified organisms
OEMs continue to improve technologies for moving and dispensing liquids and other sensitive products, but manufacturers often fail to do due diligence in selecting the right technology.
As USP updates its compendia and rapid microbial methods become more integral to industry practices, Celsis has expanded its service offerings, and its products (including an RNA-based rapid detection system). Cindy Lieberman, VP of marketing, talks about how manufacturers can stay current with, ...